The Acute Optic Neuritis Network (ACON): a Non-interventional Prospective Multicenter Study on Diagnosis and Treatment of Acute Optic Neuritis

Status: Recruiting
Location: See all (26) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this observational study is to longitudinally investigating subjects with inaugural acute optic neuritis (ON). The main questions it aims to answer are: * Does the time to corticosteroid treatment affect the visual outcome at 6 months in subjects with acute multiple sclerosis (MS)-, aquaporin 4-IgG positive (AQP4-IgG+) and myelin-oligodendrocyte-glycoprotein-IgG positive (MOG-IgG+) ON? * How differ clinical, structural, and laboratory biomarkers in subjects with acute ON, including clinical isolated syndrome (CIS), MS-ON, AQP4-IgG+ON, MOG-IgG+ON and seronegative non-MS-ON? Participants will undergo * clinical examination, including clinical history, neurovisual and neurological tests * serum and cerebrospinal fluid examination * optical coherence tomography (OCT) * magnetic resonance imaging (MRI) * assessment of depression, pain, quality of life through validated questionnaires Researchers will compare subjects with MS-ON, AQP4-IgG+ON, MOG-IgG+ON and other ON (CIS, seronegative non-MS-ON) to detect diagnostic and predictive markers for the disease course.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• First-ever acute ON

• Onset of visual symptoms within maximum of 30 days

• Age ≥ 18 years

• Ability to give written informed consent

• Presence of written consent

Locations
United States
Colorado
University of Colorado School of Medicine
NOT_YET_RECRUITING
Aurora
Massachusetts
Harvard Medical School
NOT_YET_RECRUITING
Boston
Minnesota
Departments of Neurology and Ophthalmology, Mayo Clinic
RECRUITING
Rochester
Other Locations
Argentina
Hospital Aleman
NOT_YET_RECRUITING
Buenos Aires
Australia
Department of Neurology, Concord Hospital, Faculty of Medicine and Health
RECRUITING
Sydney
Botswana
University of Botswana
NOT_YET_RECRUITING
Gaborone
Brazil
Federal University of Minas Gerais, Belo Horizonte
NOT_YET_RECRUITING
Minas Gerais
Colombia
Del Rosario University
NOT_YET_RECRUITING
Bogotá
Department of Ophthalmology, Oftlamo-Sanitas Eye Institute, School of Medicine, Fundación Universitaria Sanitas
NOT_YET_RECRUITING
Bogotá
Pontificia Universidad Javeriana
NOT_YET_RECRUITING
Bogotá
Denmark
Department of Neurology, Slagelse, Institute for Health Research, University of Southern Denmark
RECRUITING
Odense
France
(MIRCEM) Lyon Civil Hospices, France
NOT_YET_RECRUITING
Lyon
Germany
Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Germany, Department of Neurology
RECRUITING
Berlin
Institute for Clinical Neuroimmunology, LMU Clinic of Ludwig-Maximilians Universität in Munich
NOT_YET_RECRUITING
Munich
India
Nitte University, Karnataka
NOT_YET_RECRUITING
Mangalore
Israel
Hadassah Hebrew University
NOT_YET_RECRUITING
Jerusalem
Sackler School of Medicine and Rabin Medical Center
RECRUITING
Tel Aviv
Italy
University of Bologna
NOT_YET_RECRUITING
Bologna
University of Verona
RECRUITING
Verona
Japan
Fukushima Medical University School of Medicine
NOT_YET_RECRUITING
Fukushima
Republic of Korea
National Cancer Center, Seúl University
NOT_YET_RECRUITING
Seoul
Spain
University of Barcelona
NOT_YET_RECRUITING
Barcelona
Vall d'Hebron Barcelona Hospital Campus
NOT_YET_RECRUITING
Barcelona
United Kingdom
University Hospitals of Birmingham
NOT_YET_RECRUITING
Birmingham
Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital
NOT_YET_RECRUITING
Oxford
Zambia
University Teaching Hospital in Lusaka
NOT_YET_RECRUITING
Lusaka
Contact Information
Primary
Susanna Asseyer, Dr. med.
susanna.asseyer@charite.de
030450639727
Backup
Hadas Stiebel-Kalish, Prof.
kalishhadas@gmail.com
Time Frame
Start Date: 2020-08-15
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 200
Sponsors
Leads: Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul

This content was sourced from clinicaltrials.gov

Similar Clinical Trials